Bioprocessing 4.0: Digital Transformation Of Biopharmaceutical Process Development
Source: Cytiva

Digital transformation is gaining significance in the biopharmaceutical industry, as it offers new opportunities for additional value creation and competitive advantage. Digital biomanufacturing harnesses the Internet of Things to integrate contrasting sources of data, equipment, materials, and people. Combined with artificial intelligence, augmented reality, robotics, and digital twins, Biopharma 4.0 changes legacy concepts from the ground up. Learn about the benefits of Biopharma 4.0 and how digital twins are driving the next generation of bioprocesses.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.
Subscribe to Biosimilar Development
X
Subscribe to Biosimilar Development
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more